Wegovy Weight Loss Weight Management Zepbound

Jun 23, 2026
16 MIN READ

Wegovy or Zepbound: Choosing Your Path to Sustainable Weight Loss

Tirzepatide and semaglutide both reduce appetite and blood sugar, but tirzepatide activates two hormone receptors instead of one. Understanding the difference helps you choose a therapy aligned with your genetic makeup and weight loss goals.

GLP-1 weight loss starts at $129/mo Provider-reviewed options. No membership fees.

See if you qualify →

Jun 23, 2026
16 MIN READ

wegovy or zepbound: choosing your path to sustainable weight loss — PlexusDx GLP-1 education

Last reviewed: June 23, 2026

Last updated: June 23, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Both tirzepatide and semaglutide are FDA-approved glucagon-like peptide-1 (GLP-1) medications that help people lose weight by slowing digestion and reducing hunger signals. The key difference lies in their mechanisms: tirzepatide also activates the glucose-dependent insulinotropic polypeptide (GIP) receptor, making it a dual-action compound. Clinical trials show tirzepatide produces greater weight loss than semaglutide alone, with some patients losing 20–22% of body weight over 72 weeks.

How Tirzepatide and Semaglutide Work Differently

Semaglutide activates only the GLP-1 receptor, which slows stomach emptying, decreases appetite, and improves blood sugar control. This single-pathway approach works well for many people, especially those whose weight gain is driven by excessive hunger or emotional eating. Semaglutide has been studied for over a decade, and healthcare providers have extensive experience managing its side effects and dose adjustments.

Tirzepatide activates both GLP-1 and GIP receptors simultaneously. This dual-action mechanism engages two separate appetite-control pathways in your brain and pancreas. Research suggests that activating both pathways produces stronger appetite suppression and metabolic improvements than GLP-1 activation alone. In head-to-head trials, tirzepatide patients lost an average of 2–3 pounds more per month than semaglutide users at equivalent doses.

Clinical Evidence: Weight Loss Outcomes and Metabolic Benefits

The SURPASS trial family demonstrated tirzepatide's superior efficacy: participants taking the highest dose lost up to 22.5% of baseline body weight over 72 weeks, compared to 14.9% for the highest semaglutide dose in parallel studies. Tirzepatide also showed greater improvements in fasting blood sugar, cholesterol, and blood pressure—markers linked to long-term heart health. These outcomes suggest tirzepatide may offer broader metabolic benefit, particularly for people with prediabetes or metabolic syndrome alongside obesity.

Semaglutide remains highly effective for sustainable weight loss, with consistent 15–18% reductions in clinical trials and real-world data spanning longer follow-up periods. Some patients experience weight loss plateaus after 6–12 months on semaglutide, while others maintain steady progress. The choice between the two depends on your starting weight, metabolic risk factors, and how your body responds to single versus dual GLP-1/GIP activation.

Genetic Factors That Influence Your Medication Response

Your genes shape how effectively your body responds to GLP-1 and GIP receptor activation. Variations in the GLP1R gene (rs6923761) affect how sensitively your appetite-control centers respond to semaglutide or tirzepatide. Similarly, GIPR variants influence GIP receptor signaling and may predict which patients benefit most from tirzepatide's dual-action mechanism. The MC4R and FTO genes also regulate hunger signals and metabolic rate, determining whether you may need more aggressive therapy.

PlexusDx offers the Precision Peptide Genetic Test, which analyzes 14 peptide pathways and maps 150+ genetic insights including GLP1R rs6923761, GIPR rs1800437, FTO rs9939609, and MC4R rs17782313. This test reveals whether your genetics favor GLP-1 monotherapy or the dual GLP-1/GIP approach of tirzepatide. Understanding your peptide-pathway genetics helps you start with the right medication and avoid trial-and-error treatment.

Cost, Access, and Personalized Dosing at PlexusDx

PlexusDx offers compounded tirzepatide injections starting at $249 per month from licensed 503A compounding pharmacies, with no insurance required and no membership fees. Semaglutide injections begin at $149 per month. Both medications are available across all 50 states and qualify for HSA and FSA funding. Your dose may need to go up as your body adapts, but your price won't—PlexusDx uses a flat monthly rate, not flat per-compound pricing.

After your first month of treatment, PlexusDx patients can add the Precision Peptide Genetic Test for $99 to confirm whether tirzepatide or semaglutide aligns with your genetic profile. This test guides dose optimization and helps predict long-term response, reducing the time spent on a suboptimal medication. Combined with PlexusDx's telemedicine providers, you receive a truly personalized weight loss plan rather than a one-size-fits-all approach.

Common Side Effects and How They Compare

Both tirzepatide and semaglutide can cause nausea, vomiting, diarrhea, or constipation as your digestive system adjusts to slower stomach emptying. These effects typically peak during the first 2–4 weeks and subside as your body adapts. Tirzepatide side effects are generally similar in type to semaglutide but may occur more frequently or intensely because of the dual-receptor activation. Patients on tirzepatide occasionally report greater appetite suppression, which some experience as difficulty eating enough protein.

Rare but serious risks include pancreatitis, gallbladder problems, and thyroid changes—concerns that apply to both medications. Neither compound is appropriate for people with personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia type 2. Starting at the lowest effective dose and increasing gradually reduces side-effect burden. PlexusDx providers monitor your symptoms at each visit and adjust your medication or dose if needed.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection starts at $249/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Should I start with semaglutide or tirzepatide?

If you have modest weight to lose (20–50 pounds) and no prediabetes, semaglutide is a proven, cost-effective starting point. If you need to lose more than 50 pounds, have prediabetes or metabolic syndrome, or have tried semaglutide without sufficient results, tirzepatide's dual-action mechanism often produces faster, larger weight loss. The Precision Peptide Genetic Test can confirm which medication aligns with your genetic predispositions.

How much weight loss can I expect with tirzepatide?

Clinical trials show average weight loss of 20–22% of body weight over 72 weeks with tirzepatide, though individual results vary widely. Someone weighing 250 pounds might lose 50–55 pounds, while someone at 180 pounds might lose 36–40 pounds. Weight loss typically accelerates during months 2–6, then slows as your body adapts; most patients achieve their maximum loss by month 12.

How much does compounded tirzepatide cost at PlexusDx?

PlexusDx tirzepatide injections start at $249 per month with no flat per-compound pricing increases. Your dose may need to go up as treatment progresses, but your monthly price remains flat. All medications are compounded in licensed 503A pharmacies, require no insurance, and are available in all 50 states.

Are compounded semaglutide and tirzepatide safe?

Yes—PlexusDx sources all medications from licensed 503A compounding pharmacies that follow FDA sterility and potency standards. However, compounded medications are not FDA-approved in the same way brand-name Wegovy, Zepbound, or Mounjaro are. You should discuss the benefits and risks with your PlexusDx provider, especially if you have thyroid disease, pancreatitis history, or severe kidney problems.

What does the Precision Peptide Genetic Test reveal?

The test analyzes your GLP1R, GIPR, FTO, MC4R, and 10 other peptide-pathway genes to predict how strongly you'll respond to GLP-1, GIP, or dual-action therapy. Specific variants like GLP1R rs6923761 and GIPR rs1800437 may indicate whether tirzepatide's dual mechanism will outperform semaglutide for your body. At $99 after your first month, the test guides dose optimization and medication selection.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves